Dr Reddys Laboratories (RDY) Enterprise Value (2017 - 2025)
Dr Reddys Laboratories (RDY) has 8 years of Enterprise Value data on record, last reported at -$87.6 million in Q1 2024.
- For Q1 2024, Enterprise Value fell 2.73% year-over-year to -$87.6 million; the TTM value through Mar 2024 reached -$87.6 million, down 2.73%, while the annual FY2025 figure was -$678.0 million, 671.38% down from the prior year.
- Enterprise Value reached -$87.6 million in Q1 2024 per RDY's latest filing, down from -$85.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$43.6 million in Q1 2020 and bottomed at -$474.2 million in Q1 2021.
- Average Enterprise Value over 5 years is -$182.7 million, with a median of -$87.6 million recorded in 2024.
- Peak YoY movement for Enterprise Value: skyrocketed 87.58% in 2020, then plummeted 987.74% in 2021.
- A 5-year view of Enterprise Value shows it stood at -$43.6 million in 2020, then tumbled by 987.74% to -$474.2 million in 2021, then soared by 53.0% to -$222.9 million in 2022, then soared by 61.73% to -$85.3 million in 2023, then dropped by 2.73% to -$87.6 million in 2024.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$87.6 million in Q1 2024, -$85.3 million in Q1 2023, and -$222.9 million in Q1 2022.